NEU
Neuren Pharmaceuticals Limited
About NEU
Neuren Pharmaceuticals Limited (NEU) is a biopharmaceutical company developing therapies for brain injury, neurodevelopmental and neurodegenerative disorders. NEU has two key drug products comprising NNZ-2566 and NNZ-2591. NEU has operations in New Zealand, Australia and the USA.
Buy Australian shares starting with NEU. Invest today with a CHESS-sponsored broker!
Market Capitalisation
$1.64B
Price-earnings ratio
8786.67
Dividend yield
0.00%
High today
$13.46
Low today
$12.83
Open price
$13.20
52-week high
$13.46
52-week low
$3.33
Announcements
NEU FAQs
How much is one share of Neuren Pharmaceuticals Limited?
One share of Neuren Pharmaceuticals Limited is valued at $13.05.
What is the ticker symbol for Neuren Pharmaceuticals Limited?
The ticker symbol for Neuren Pharmaceuticals Limited is NEU.
How do I buy NEU shares in Australia?
To buy NEU stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:
To do so follow these steps:
- Sign up in minutes, all you need is some I.D.
- Choose Stake AUS
- Deposit directly into your Stake wallet and you're ready to invest in NEU
What is the 52-week high for Neuren Pharmaceuticals Limited stock?
The Neuren Pharmaceuticals Limited 52-week high stock price is $13.46.
What is the 52-week low for Neuren Pharmaceuticals Limited stock?
The Neuren Pharmaceuticals Limited 52-week low stock price is $3.33.
What is the market capitalisation of Neuren Pharmaceuticals Limited NEU?
As of 25/03/2023 Neuren Pharmaceuticals Limited has a market cap of $1.64B.
Related Stocks
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.